Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes

被引:29
|
作者
Nolan, J. J. [1 ]
F'rch, K. [1 ]
机构
[1] Steno Diabet Ctr AS, DK-2820 Gentofte, Denmark
基金
美国国家卫生研究院;
关键词
Diabetes; Insulin resistance; Insulin secretion; Mathematical model; Obesity; IMPAIRED GLUCOSE-TOLERANCE; RESISTANCE; HOMA; PREVENTION; SECRETION; EXERCISE; DIET;
D O I
10.1007/s00125-012-2684-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 1985 manuscript describing the HOMA model, by Matthews and colleagues, is the most cited paper in the history of Diabetologia. In this edition of 'Then and now' we assess the impact of this seminal paper by considering the contribution of this elegant work in the context of the most rapidly changing period in the history of diabetes. HOMA was born in the middle of an 'era' of insulin resistance, and was subsequently nurtured and grew during the 'eras' of insulin sensitisers and diabetes prevention. From the modern era of insulin resistance onward, researchers have sought a convenient method for measuring insulin sensitivity and secretion, and found this in HOMA. However, the explosion in the prevalence of diabetes clearly underlines that an understanding of insulin resistance and how it can be measured has been insufficient to make any impact on the growing pandemic of diabetes. Knowledge of individual physiology is important, but the dramatic impact of the modern environment may be the factor that has escaped attention until very recently. An optimist can only state that the coming 'era' in diabetes research will be a period of true translation of scientific insight and implementation of effective disease prevention.
引用
收藏
页码:2863 / 2867
页数:5
相关论文
共 50 条
  • [1] Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes
    J. J. Nolan
    K. Færch
    Diabetologia, 2012, 55 : 2863 - 2867
  • [2] Insulin sensitivity, beta cell function and subclinical inflammation in the baboon, a non human primate model of insulin resistance, obesity and type 2 diabetes
    Folli, F.
    Casiraghi, F.
    Davalli, A. M.
    Kamath, S.
    Ricotti, A.
    Chang, Z.
    Gastaldelli, A.
    Abrahamian, G. A.
    Halff, G. A.
    DeFronzo, R. A.
    Chavez, A. O.
    DIABETOLOGIA, 2011, 54 : S272 - S273
  • [3] Orforglipron Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes
    Rosenstock, Julio
    Robins, Deborah A.
    Duffin, Kevin L.
    Wilson, Jonathan M.
    Mather, Kieren J.
    Banerjee, Hiya
    Lin, Yanzhu
    Eyde, Sarah
    Kazda, Christof M.
    Konig, Manige
    DIABETES, 2024, 73
  • [4] Type 1 diabetes: influence of age on beta cell function and insulin sensitivity
    Kessing, Richard
    DIABETOLOGIE UND STOFFWECHSEL, 2023, 18 (03) : 180 - 180
  • [5] Dorzagliatin in combination with sitagliptin improves insulin sensitivity and beta cell function in patients with type 2 diabetes
    Zhang, Y.
    Feng, L.
    Zhang, J.
    Liu, H.
    Jiang, M.
    Chen, L.
    Liu, D.
    DIABETOLOGIA, 2024, 67 : S335 - S335
  • [6] Changes in Pancreatic Beta Cell Function and Insulin Sensitivity in Type 2 Diabetes by Continuous Subcutaneous Insulin Infusion Therapy for 2 Years
    Choi, Soo Bong
    An, Hyun-Ju
    Kim, Kyung-Jin
    Jeon, Eun-Kyoung
    Noh, Yun-Hee
    DIABETES, 2013, 62 : A251 - A251
  • [7] Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes
    Kumar, Hemant
    Mishra, Manish
    Bajpai, Surabhi
    Pokhria, Deepa
    Arya, Awadhesh Kumar
    Singh, Rakesh Kumar
    Tripathi, Kamlakar
    ACTA DIABETOLOGICA, 2013, 50 (04) : 511 - 518
  • [8] Longitudinal trajectories of insulin sensitivity and beta cell function before the development of type 2 diabetes in Japanese individuals
    Heianza, Y.
    Arase, Y.
    Kodama, S.
    Tsuji, H.
    Tanaka, S.
    Kobayashi, T.
    Hara, S.
    Sone, H.
    DIABETOLOGIA, 2015, 58 : S21 - S21
  • [9] Effects of Exenatide Plus Rosiglitazone on Beta Cell Function and Insulin Sensitivity in Subjects with Type 2 Diabetes on Metformin
    Defronzo, Ralph A.
    Triplitt, Curtis
    Qu, Yongming
    Lewis, Michelle S.
    Gray, Alison
    Maggs, David
    Glass, Leonard C.
    DIABETES, 2009, 58 : A133 - A134
  • [10] Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes
    Hemant Kumar
    Manish Mishra
    Surabhi Bajpai
    Deepa Pokhria
    Awadhesh Kumar Arya
    Rakesh Kumar Singh
    Kamlakar Tripathi
    Acta Diabetologica, 2013, 50 : 511 - 518